Terms: = Leukemia AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
6 results:
1. Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression.
Du A; Yang Q; Sun X; Zhao Q
Int Immunopharmacol; 2023 Nov; 124(Pt A):110868. PubMed ID: 37657244
[TBL] [Abstract] [Full Text] [Related]
2. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia.
Ren JG; Xing B; Lv K; O'Keefe RA; Wu M; Wang R; Bauer KM; Ghazaryan A; Burslem GM; Zhang J; O'Connell RM; Pillai V; Hexner EO; Philips MR; Tong W
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317963
[TBL] [Abstract] [Full Text] [Related]
3. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via raf-1 independent activation of MEK/ERK.
Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X
Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849
[TBL] [Abstract] [Full Text] [Related]
4. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract] [Full Text] [Related]
5. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies.
Ricciardi MR; Scerpa MC; Bergamo P; Ciuffreda L; Petrucci MT; Chiaretti S; Tavolaro S; Mascolo MG; Abrams SL; Steelman LS; Tsao T; Marchetti A; Konopleva M; Del Bufalo D; Cognetti F; Foà R; Andreeff M; McCubrey JA; Tafuri A; Milella M
J Mol Med (Berl); 2012 Oct; 90(10):1133-44. PubMed ID: 22399013
[TBL] [Abstract] [Full Text] [Related]